8-K/A
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-05-006484
New debt or obligation
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading c39069_8ka.txt…